Solitary papillary muscle hypertrophy: a new echo-electrocardiographic syndrome? A case report

J Ker1

  • 1University of Pretoria and Pretoria Heart Hospital, Pretoria, South Africa. jker@wol.co.za

Angiology
|July 20, 2007
PubMed

Insights

Solitary papillary muscle hypertrophy is a rare condition in hypertrophic cardiomyopathy. Hypertrophy of the anterior papillary muscle may represent a novel echo-electrocardiographic syndrome.

Area of Science:

  • Cardiology
  • Genetics
  • Biomedical Engineering

Background:

  • Hypertrophic cardiomyopathy (HCM) encompasses diverse genetic disorders affecting cardiac sarcomere proteins, leading to left ventricular hypertrophy.
  • HCM-related hypertrophy can manifest variably, affecting single or multiple ventricular segments, including the septum, free wall, mid-ventricle, or apex, and can be symmetric or asymmetric.

Observation:

  • Solitary papillary muscle hypertrophy is an exceptionally rare finding, with limited documentation in existing literature.
  • Giant negative T and U waves on electrocardiograms are common in HCM and have been linked to posterior papillary muscle hypertrophy.

Findings:

  • This study explores the potential of solitary anterior papillary muscle hypertrophy as a distinct clinical entity.
  • The findings suggest a possible association between anterior papillary muscle hypertrophy and specific electrocardiographic patterns.

Implications:

  • Identifying solitary anterior papillary muscle hypertrophy could lead to a new diagnostic syndrome, combining echocardiography and electrocardiography.
  • This may enhance the understanding and diagnosis of rare hypertrophic cardiomyopathy variants.
  • Further research is warranted to confirm this novel echo-electrocardiographic syndrome and its clinical significance.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...